 |
인쇄하기
취소
|
Bukwang authorized to resell Levovir, KFDA says
The Korea Food and Drug Administration has allowed Bukwang Pharm to remarket Levovir, saying the benefits of the product outweigh the risks.
Levovir is an antiviral agent for treatment of hepatitis caused by the hepatitis B virus based on DNA polymerase inhibition.
The drug agency said in its letter that adverse reactions developed in Levovir is reversible after discontinuation of the dru...
Levovir is an antiviral agent for treatment of hepatitis caused by the hepatitis B virus based on DNA polymerase inhibition.
The drug agency said in its letter that adverse reactions developed in Levovir is reversible after discontinuation of the dru...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.